# Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11

> **NCT00015301** · PHASE4 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)**

## Conditions studied

- Cocaine-Related Disorders
- Substance-Related Disorders

## Interventions

- **DRUG:** Methylphenidate

## Key facts

- **NCT ID:** NCT00015301
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-12
- **Primary completion:** 2005-06
- **Final completion:** 2005-08
- **Target enrollment:** 0 (—)
- **Last updated:** 2017-02-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00015301

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00015301, "Methylphenidate Raclopride Positron Emission Tomography (PET) Test - 11". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00015301. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
